Reducing bloodstream infection with a chlorhexidine gel IV dressing.
The use of vascular access devices (VAD) is common in healthcare provision but there is a significant risk of acquiring an infection. Central venous catheters (CVC) are associated with the highest risk of intravenous catheter-related bloodstream infection (CRBSI). 3M™ Tegaderm™ CHG IV dressing is a semi-permeable transparent adhesive dressing with an integrated gel pad containing chlorhexidine gluconate 2%. This product was reviewed by the National Institute for Health and Care Excellence (NICE) in 2015, recommending that Tegaderm CHG could be used for CVC and arterial line dressings in high-dependency and intensive-care settings. This article discusses issues around CRBSI, interventions to reduce the risk of CRBSI, and the use of Tegaderm CHG dressing.
Consultant Nurse Infection Control and Director of Infection Prevention and Control.
Annette
A
Jeanes
Infection Control Intravenous Clinical Nurse Specialist, both at University College London Hospitals NHS Foundation Trust, London.
James
J
Bitmead
D000328:Adult; D000891:Anti-Infective Agents, Local / Q000627:therapeutic use*; D001458:Bandages; D055499:Catheter-Related Infections / Q000209:etiology* / Q000517:prevention & control*; D062905:Central Venous Catheters / Q000009:adverse effects*; D002710:Chlorhexidine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged
D000891:Anti-Infective Agents, Local; C010882:chlorhexidine gluconate; D002710:Chlorhexidine
Catheter securement; Catheter-related bloodstream infection; Central line-associated bloodstream infection; Central venous catheters; Healthcare-associated infection